HubXchange Boston 2022 – March 15
Roundtable Discussion

Natalie LaFranzo, PhD
Personalis, Inc.
Tuesday, March 15
Beyond MRD: Developing Patient-Centered Diagnostics through Tumor-Informed Comprehensive Insights
- Earlier detection of disease recurrence
- Utility in more disease indications, and at earlier stages of disease
- Clinical trial needs for patient enrichment
- Screening/enrollment
- Surrogate endpoint analysis
- Necessity for additional biomarker readouts
HubXchange Boston, March 15, 2022